Differential Type-I Interferon Response in Buffy Coat Transcriptome of Individuals Infected with SARS-CoV-2 Gamma and Delta Variants

Guilherme Cordenonsi da Fonseca, Liliane Cavalcante, Otávio José Bernandes Brustolini, Paula M. Luz, Débora Castanheira, Emília M. Jalil, Eduardo Mesquita Peixoto, Beatriz Grinsztejn, Valdiléa G. Veloso, Sandro Nazer, Carlos A. M. Costa, Daniel Antunes Maciel Villela, Guilherme Tegoni Goedert, Cléber Vinícius Brito dos Santos, Nádia Cristina Pinheiro Rodrigues, Fernando Couto Motta, Marilda Mendonça Siqueira, Lara E. Coelho, Claúdio J. Struchiner, Ana Tereza Ribeiro de VasconcelosInternational Journal of Molecular Sciences 2023 · DOI

TL;DR

This study investigates how SARS-CoV-2 variants, specifically Gamma and Delta, differentially impact the human immune response. Researchers found that the Delta variant elicits a stronger innate immune and type-I interferon (IFN) response compared to the Gamma variant, which seems to have evolved mechanisms to evade this crucial defense.

What Problem Does This Paper Address?

The innate immune system is our body's first line of defense against viral invaders like SARS-CoV-2. A key component of this defense is the type-I interferon (IFN) response, which is critical for controlling viral replication and preventing severe disease. However, SARS-CoV-2 has evolved ways to suppress this IFN response, and individuals with a weakened IFN response are more prone to severe COVID-19. With the emergence of new SARS-CoV-2 variants, each carrying different mutations, there's a pressing need to understand how these genetic changes affect the virus's ability to evade or manipulate the host's immune system, particularly the IFN response. This paper aims to elucidate these differences between the Gamma and Delta variants by examining their impact on the host's transcriptome.

Methods

The researchers employed a multi-pronged approach to analyze the immune response:

  • Transcriptome Analysis: They performed RNA sequencing on buffy coat samples (a component of blood containing white blood cells and platelets) from individuals infected with either the Delta or Gamma variant, as well as healthy controls. This allowed them to identify differentially expressed genes (DEGs) – genes that are significantly up- or down-regulated in infected individuals compared to controls.
  • Gene Ontology (GO) and Reactome Enrichment Analysis: Standard bioinformatics tools were used to identify biological pathways and functions that were overrepresented among the DEGs. This helps to understand the broader cellular processes affected by each variant.
  • Promoter Motif Enrichment Analysis: This technique was used to identify transcription factor binding sites enriched in the regulatory regions of genes, providing insights into how gene expression is controlled.
  • Interactome Analysis: They constructed protein-protein interaction networks to visualize how DEGs and viral proteins interact within the host cell, highlighting potential key players and pathways.
  • Mutation Analysis: The study specifically looked for mutations in SARS-CoV-2 proteins that have been previously linked to interfering with the IFN response.

Datasets

The study utilized buffy coat samples from:

  • Seven individuals infected with the Delta variant.
  • Nine individuals infected with the Gamma variant.
  • Eight healthy controls.

The gene expression data generated from these samples was deposited in the Gene Expression Omnibus (GEO) database under accession number PRJNA952972. SARS-CoV-2 genome sequences were deposited in GISAID.

Key Insights and Ideas

  • Delta's Pro-Innate, Gamma's Pro-Adaptive Lean: While both variants triggered immune responses, Delta showed a stronger enrichment in innate immune response genes, whereas Gamma leaned more towards adaptive immune response pathways. This suggests a fundamental difference in how these variants engage the host's defenses.
  • Delta's Superior IFN Activation: The interactome and promoter analysis strongly indicated that the Delta variant is more effective at activating the type-I IFN response compared to the Gamma variant. This is a critical finding, as IFN is a primary antiviral mechanism.
  • Gamma's Evasive Mutations: The identification of specific mutations in Gamma's N and nsp6 proteins, known to inhibit the IFN response, provides a molecular explanation for its ability to evade this crucial immune defense. This highlights an evolutionary strategy for immune evasion.
  • Distinct Viral Protein Interactions: The interactome analysis revealed that SARS-CoV-2 proteins, particularly the N protein, interacted with a larger number of host proteins in Delta-infected individuals, suggesting a more widespread impact on host cellular machinery.

Key Results

  • Differential Gene Expression: The Delta group had 442 upregulated and 240 downregulated DEGs, while the Gamma group had 653 DEGs (370 upregulated, 283 downregulated).
  • Innate vs. Adaptive Focus: GO enrichment showed that Delta had more genes related to the innate immune response, while Gamma had more related to the adaptive immune response.
  • IFN Pathway Activation: Delta showed a more robust activation of IFN-related pathways, with key regulators like IRF7, IRF2, and IRF1 being enriched.
  • Gamma's IFN Evasion Mutations: Three specific mutations were identified in Gamma (two in the N protein, one in nsp6) that are known to inhibit the IFN response.
  • Interactome Network Size: The Delta interactome network was larger, involving 77 DEGs and 25 SARS-CoV-2 genes, compared to Gamma's network with 24 DEGs and 21 SARS-CoV-2 genes.

Limitations and Future Work

  • Small Sample Size: The study acknowledges that the low number of cases (24 individuals) limits the ability to draw broad demographic conclusions.
  • Focus on Buffy Coat: While buffy coat provides valuable insights into immune cell responses, it doesn't represent the full picture of the immune response in all affected tissues.
  • Further Mechanistic Studies: The authors suggest that future research should delve deeper into the precise molecular mechanisms by which these mutations confer resistance to the IFN response and explore the broader implications for disease severity and transmission. Investigating the role of asymptomatic transmission, which is more prevalent with variants like Omicron (which shares some mutations with Gamma), is also highlighted as an important area for future work.

Summary updated

Abstract

The innate immune system is the first line of defense against pathogens such as the acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The type I-interferon (IFN) response activation during the initial steps of infection is essential to prevent viral replication and tissue damage. SARS-CoV and SARS-CoV-2 can inhibit this activation, and individuals with a dysregulated IFN-I response are more likely to develop severe disease. Several mutations in different variants of SARS-CoV-2 have shown the potential to interfere with the immune system. Here, we evaluated the buffy coat transcriptome of individuals infected with Gamma or Delta variants of SARS-CoV-2. The Delta transcriptome presents more genes enriched in the innate immune response and Gamma in the adaptive immune response. Interactome and enriched promoter analysis showed that Delta could activate the INF-I response more effectively than Gamma. Two mutations in the N protein and one in the nsp6 protein found exclusively in Gamma have already been described as inhibitors of the interferon response pathway. This indicates that the Gamma variant evolved to evade the IFN-I response. Accordingly, in this work, we showed one of the mechanisms that variants of SARS-CoV-2 can use to avoid or interfere with the host Immune system.
BibTeX
@article{fonseca2023differential,
  author = {Guilherme Cordenonsi da Fonseca and Liliane Cavalcante and Otávio José Bernandes Brustolini and Paula M. Luz and Débora Castanheira and Emília M. Jalil and Eduardo Mesquita Peixoto and Beatriz Grinsztejn and Valdiléa G. Veloso and Sandro Nazer and Carlos A. M. Costa and Daniel Antunes Maciel Villela and Guilherme Tegoni Goedert and Cléber Vinícius Brito dos Santos and Nádia Cristina Pinheiro Rodrigues and Fernando Couto Motta and Marilda Mendonça Siqueira and Lara E. Coelho and Claúdio J. Struchiner and Ana Tereza Ribeiro de Vasconcelos},
  title = {{Differential Type-I Interferon Response in Buffy Coat Transcriptome of Individuals Infected with SARS-CoV-2 Gamma and Delta Variants}},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241713146},
}
Figure